Skip to content

Advertisement

Volume 8 Supplement 2

Frontiers of Retrovirology 2011

  • Oral presentation
  • Open Access

The Retrovirology open access experience

  • 1
Retrovirology20118 (Suppl 2) :O26

https://doi.org/10.1186/1742-4690-8-S2-O26

  • Published:

Keywords

  • Infectious Disease
  • Cancer Research
  • Open Access
  • Impact Factor
  • High Impact

The Open Access (OA) model of publishing has revolutionized the egalitarian distribution of knowledge, especially to those who are least able financially to pay for subscription access. Because OA journals are newer ventures, they face several challenges. They often lack the track record and established reputation necessary to attract the best quality submissions. In general, most OA journals also do not sport the high Impact Factors numbers that many scientists consider to be crucial for advancing their careers. How then does one go about starting and continuing a successful OA journal? I have written briefly in the past about Retrovirology's Open Access experience [1] and the process that we go through to develop recognition [2] for our authors and citation and visibility [3] for Retrovirology papers. Here, I will discuss some of these issues in greater depth and touch on the realities and perceptions about OA journals.

Authors’ Affiliations

(1)
Editor-in-Chief, Retrovirology, UK

References

  1. Jeang KT: The Retrovirology Open Access experience. Retrovirology. 2009, 6: 115-10.1186/1742-4690-6-115.PubMed CentralView ArticlePubMedGoogle Scholar
  2. Jeang KT: Prizes and Heroes: Lagging and leading indicators. Retrovirology. 2010, 7: 87-10.1186/1742-4690-7-87.PubMed CentralView ArticlePubMedGoogle Scholar
  3. Jeang KT: The importance of individualized article-specific metrics for evaluating research productivity. Retrovirology. 2009, 6: 82-10.1186/1742-4690-6-82.PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

© Jeang; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement